Yondelis 1mg Injection 1s
Yondelis 1mg Injection 1s is classified as an 'anti-cancer' medication used to treat various cancers such as ovarian cancer and soft tissue sarcoma. Cancer is characterized by uncontrolled growth and reproduction of cells in a specific body part. Breast cancer originates in breast cells, while liposarcoma is a rare cancer that develops in fatty tissue. It works by binding to DNA in cells and causing damage, preventing cancer cells from growing and multiplying.
Yondelis 1mg Injection 1s is given as an injection under the medical supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include headache, fatigue, vomiting, weakness, and increased liver enzymes. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with your heart, liver, and kidney. Generally, avoid alcohol consumption while on treatment.
Before taking it, tell your doctor if have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Similar Medicines
More medicines by Janssen Pharmaceuticals
Related Faqs

Is Relimide FDA approved?
Relimide a medication approved by the US Food and Drug Administration FDA offers a promising solution for various medical conditions This groundbreaking drug has undergone rigorous testing and quality control measures to ensure its safety and efficacy By meeting the strict criteria set by the FDA Relimide has proven to be a reliable treatment option for patients in need With its approval Relimide has opened doors for individuals suffering from a range of ailments From chronic diseases to acute conditions this drug has the potential to alleviate symptoms and improve overall quality of life Its success can be attributed to the extensive research and clinical trials that have demonstrated its effectiveness Relimides approval by the FDA signifies a significant milestone in the medical field This recognition not only showcases the drugs ability to meet the highest standards of safety and effectiveness but also grants physicians and patients alike the confidence to trust in its therapeutic properties Moreover the rigorous approval process ensures that Relimide is manufactured and distributed according to strict regulations guaranteeing consistency and reliability in its administration As patients continue to benefit from Relimide ongoing research and development efforts aim to expand its applications further Medical professionals are exploring its potential uses in different patient populations and exploring additional therapeutic benefits The FDAs stamp of approval has not only validated the drugs efficacy but has also provided a platform for continued advancements in medical treatment Overall Relimides FDA endorsement has brought muchneeded hope and relief to countless individuals serving as a testament to the power of innovative pharmaceutical solutions
Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.
Yondelis 1mg Injection 1s
Prescription Required
Packaging :
vial of 1 Injection
Manufacturer :
Janssen PharmaceuticalsComposition :
Trabectedin (1mg)